| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 259,120 | 265,723 | 236,455 | 243,293 | | Cost of Revenue | 128,643 | 127,283 | 112,022 | 122,772 | | | Gross Profit | 130,477 | 138,440 | 124,433 | 120,521 | | | Operating Expenses | | Research Development | 16,583 | 16,594 | 15,939 | 17,184 | | Selling General and Administrative | 69,689 | 72,670 | 70,053 | 67,488 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 44,205 | 49,176 | 38,441 | 35,849 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 48 | 56 | 244 | 522 | | Earnings Before Interest And Taxes | 44,253 | 49,232 | 38,685 | 36,371 | | Interest Expense | 436 | 459 | 640 | 1,103 | | Income Before Tax | 43,817 | 48,773 | 38,045 | 35,268 | | Income Tax Expense | 12,281 | 15,106 | 11,974 | 11,713 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 31,536 | 33,667 | 26,071 | 23,555 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 31,536 | 33,667 | 26,071 | 23,555 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $31,536 | $33,667 | $26,071 | $23,555 |
|
0.17% Nasdaq 
Income Statement
